Sheela Tejwani, MD
Internal Medicine · Detroit, MINPI 1184792624
Payments from drug & device makers
Across 338 payments — averaging $2107.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$320K
- AVEO Pharmaceuticals, Inc.$179K
- Janssen Research & Development, LLC$72K
- Genentech, Inc.$41K
- Pfizer$40K
- Clovis Oncology, Inc.$22K
- plus $38K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 95 | $319,672 |
| AVEO Pharmaceuticals, Inc. | 154 | $179,444 |
| Janssen Research & Development, LLC | 10 | $71,512 |
| Genentech, Inc. | 1 | $41,300 |
| Pfizer | 17 | $39,913 |
| Clovis Oncology, Inc. | 6 | $21,875 |
| AstraZeneca | 7 | $16,947 |
| EMD Serono, Inc. | 9 | $6,092 |
| Johnson & Johnson | 10 | $5,945 |
| Seagen Inc. | 7 | $5,810 |
| Dendreon Pharmaceuticals LLC | 3 | $1,385 |
| F. Hoffmann-la Roche AG | 4 | $1,316 |
| Aadi Bioscience, Inc. | 1 | $247 |
| Lilly USA, LLC | 2 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $132 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $100 |
| Ipsen Biopharmaceuticals, Inc | 1 | $100 |
| Exelixis Inc. | 1 | $66 |
| Gilead | 2 | $47 |
| Bayer | 1 | $23 |
| Genentech USA, Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$712,212 in reported general payments places this provider in the 95th percentile of 4,567 internal medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Detroit
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Rana BalboulDetroit$2.4M
- Philip KuriakoseDetroit$1.9M
- Erlene SeymourDetroit$797K
- Vrushali DabakDetroit$509K
- James McCordDetroit$493K
- Saroj NeupaneDetroit$487K
- David StocktonDetroit$402K
- Randall BensonDetroit$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.